相关实验视频
Updated: Jun 24, 2025

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
18.5K
精神分裂症的药物治疗:我们走了多远?
1Donald and Barbara Zucker School of Medicine at Hofstra-Northwell, Feinstein Institutes of Medical Research-Institute of Behavioral Science Zucker Hillside Hospital-Northwell Health Glen Oaks NY United States.
PCN reports : psychiatry and clinical neurosciences
|June 13, 2024
概括
对精神分裂症的抗精神病药物治疗已经超越了症状管理,专注于恢复和个性化护理. 进展包括分层方法,解决不服药问题,以及开发新药以提高疗效和安全性.
科学领域:
- 心理药理学 心理药理学
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
背景情况:
- 抗精神病药物是精神分裂症治疗的核心.
- 尽管使用了几十年,但最佳的处方和患者的结果仍然是积极研究和开发的领域.
研究的目的:
- 审查精神分裂症心理药物治疗的关键进展.
- 突出治疗目标的转变,患者分层,坚持识别,维护策略和新药开发.
主要方法:
- 文献综述侧重于精神分裂症药物治疗进化的五个关键领域.
- 分析治疗结果的转变,个性化医疗方法,坚持因素,维护方案和新兴抗精神病药物的分析.
主要成果:
- 治疗的重点已经从减轻症状转向整体恢复.
- 分层的方法和承认不遵守是个性化护理的关键.
- 新的抗精神病药物化合物提供了更好的疗效和安全性,尽管现实世界的转化益处正在进行中.
结论:
- 在精神分裂症药物治疗方面取得了重大进展,强调康复和个性化治疗.
- 将研究效率转化为基于社区的改进需要解决实施障碍.
- 未来的方向包括开发新的药物和干预措施,以克服现实世界的治疗挑战.
相关概念视频
Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Psychosis and Antipsychotic Drugs: Overview
234
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
234
Antipsychotic Drugs: Typical and Atypical Agents
182
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
182
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
569
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
569
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179

